Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ScarASC: Stem Cells for Burn Scars
NCT07635875Phase 2Recruiting
- Sponsor
- Rigshospitalet
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic adipose-derived mesenchymal stromal cells in Hypertrophic Scar (HS), sponsored by Rigshospitalet. Started Apr 2026; status: recruiting.
02
Drugs
allogeneic adipose-derived mesenchymal stromal cells
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT07635875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635875.